Cardiol Therapeutics Inc Class A Earnings

The next earnings date for Cardiol Therapeutics Inc Class A is April 1, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Cardiol Therapeutics Inc Class A Earnings

Report Date	Estimated Earnings Per Share
04/01/2026	$-0.08

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Cardiol Therapeutics Inc Class A Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
11/18/2025	---	$-0.12	-54.84%
08/18/2025	---	$-0.10	-0.30%
05/12/2025	After Market	$-0.10	-25.00%
03/31/2025	After Market	---	---
11/12/2024	After Market	$-0.18	-125.00%
08/12/2024	After Market	$-0.10	23.08%
04/01/2024	After Market	$-0.12	0.00%
03/28/2024	After Market	$-0.09	0.00%
11/14/2023	After Market	$-0.09	25.00%
08/10/2023	After Market	$-0.12	0.00%
05/15/2023	After Market	$-0.11	26.67%
03/30/2023	After Market	$-0.12	20.00%
11/10/2022	After Market	$-0.13	7.14%
08/10/2022	After Market	$-0.10	33.33%
05/15/2022	After Market	$-0.14	6.67%
03/22/2022	---	$-0.11	21.43%
11/16/2021	Before Market	$-0.18	-0.22%
08/17/2021	Before Market	$-0.16	-14.29%
05/18/2021	Before Market	$-0.26	-85.71%
03/31/2021	Before Market	$-0.15	-25.00%
11/12/2020	After Market	$-0.10	-49.19%
08/13/2020	After Market	$-0.10	---
05/13/2020	After Market	$-0.11	31.25%
03/26/2020	After Market	$-0.12	7.69%
11/11/2019	After Market	$-0.09	---
08/13/2019	Before Market	$-0.10	---
05/08/2019	After Market	$-0.10	-43.93%
03/28/2019	After Market	$-0.10	---
12/31/2018	---	$-0.41	---
09/30/2018	---	$-0.25	---
06/30/2018	---	$-0.07	---
03/31/2018	---	$-0.03	---
12/31/2017	---	$-0.03	---
09/30/2017	---	$-0.03	---
06/30/2017	---	$-0.03	---

More About Cardiol Therapeutics Inc Class A

Website

https://www.cardiolrx.com

Country

USA

Full Time Employees

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

“Cardiol Therapeutics Inc Class A Earnings” Can Refer to the Cardiol Therapeutics Inc Class A Earnings Date

Some people say “Cardiol Therapeutics Inc Class A earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Cardiol Therapeutics Inc Class A position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Cardiol Therapeutics Inc Class A Stock on the Earnings Date

If you own Cardiol Therapeutics Inc Class A stock (CRDL) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Cardiol Therapeutics Inc Class A might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Cardiol Therapeutics Inc Class A shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Cardiol Therapeutics Inc Class A Earnings

You can contact us any time if you would like to ask questions about Cardiol Therapeutics Inc Class A earnings or anything else related to the stock market.